Skip to main content

Table 3 Multivariate analysis for prognostic factors

From: Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification

Subject

HR

CI 95%

P value

OS

Age

0.331

0.160–0.683

0.003

Tumor size

0.262

0.098–0.699

0.007

EQD2(point A)

2.530

1.159–5.521

0.036

DFS

Age

0.462

0.232–0.920

0.028

EFI

1.927

1.000–3.714

0.050

EQD2(point A)

2.949

1.379–6.306

0.005

LCR

Tumor size

0.091

0.011–0.745

0.026

Age

0.266

0.084–0.843

0.024

EQD2(point A)

5.578

1.795–17.332

0.003

OFRFS

Concurrent chemotherapy

2.738

1.248–6.009

0.012

EFI

3.287

1.369–7.892

0.008